Wellgistics Health, Inc.: Wellgistics Targets $70B Market Breakthrough Addressing Ozempic / GLP-1 Muscle Loss with Forzet

GLP-1 agonist market expected to grow from $70B in 2025 to $201B in 20301Proprietary Forzet formulation provides pharmacists, ...
Nasdaq

Elevai Biosciences, a Subsidiary of Elevai Labs Inc., Expands Patent Portfolio with Two New Filings for EL-22 in Muscle Loss Treatment for Obese Patients, Including GLP-1 ...

Filed two patent applications for lead candidate EL-22, covering muscle loss in obese patients as a monotherapy and in combination with GLP-1 receptor agonists Elevai Biosciences patent portfolio now ...
FOX40 News

The Brookbush Institute Enhances Physiology Education with an Update to the Course 'Functional Roles of Muscles'

- Agonist: Muscles that perform a joint action, including the prime mover and synergists - Prime Mover: The muscle contributing the most force to a joint action when resisted by an external load. - ...